HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator.

AuthorsMilton Packer
JournalCirculation. Arrhythmia and electrophysiology (Circ Arrhythm Electrophysiol) Vol. 12 Issue 6 Pg. e007430 (06 2019) ISSN: 1941-3084 [Electronic] United States
PMID31159583 (Publication Type: Journal Article, Review)
Chemical References
  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Anti-Arrhythmia Agents
  • Cardiovascular Agents
  • Mineralocorticoid Receptor Antagonists
  • Protease Inhibitors
  • Neprilysin
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Angiotensin Receptor Antagonists (therapeutic use)
  • Anti-Arrhythmia Agents (therapeutic use)
  • Arrhythmias, Cardiac (diagnosis, mortality, physiopathology, therapy)
  • Cardiac Resynchronization Therapy (adverse effects, mortality)
  • Cardiovascular Agents (adverse effects, therapeutic use)
  • Death, Sudden, Cardiac (prevention & control)
  • Defibrillators, Implantable
  • Electric Countershock (adverse effects, instrumentation, mortality)
  • Heart Failure (diagnosis, mortality, physiopathology, therapy)
  • Heart Rate (drug effects)
  • Humans
  • Mineralocorticoid Receptor Antagonists (therapeutic use)
  • Neprilysin (antagonists & inhibitors)
  • Protease Inhibitors (therapeutic use)
  • Risk Factors
  • Stroke Volume (drug effects)
  • Treatment Outcome
  • Ventricular Function, Left (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: